文章核心观点 - 电动汽车行业虽会持续增长但并非每家电动汽车公司都值得投资 Lucid公司面临诸多挑战股票不值得购买 [1] 竞争方面 - 特斯拉是Lucid想成为的公司特斯拉有正利润和自由现金流但2023年为维持销售降价且营收未增长利润率被压缩汽车行业面临供应增加需求跟不上压低价格和利润率的挑战 [2] - Lucid面临的挑战比特斯拉更大其毛利润率为负106%且无好转迹象 [3] 产品与成本方面 - Lucid车辆起价69900美元较贵超出普通买家承受范围难以扩大规模今年预计生产9000辆需求不足 [4] - Lucid成本下降速度跟不上公司规模在豪华车市场本就是低销量市场若在这种价格点小批量都无法盈利前景艰难 [5] 债务与现金流方面 - Lucid亏损不断增加投资者需考虑其能支撑亏损多久沙特阿拉伯公共投资基金是其最大股东虽承诺投资但新资金优先于普通股股东 [6] - Lucid背负20.47亿美元债务现金不断减少只有约一年现金量且股价下跌使新的融资更难 [7][8] - Lucid自由现金流为负且数额较大处于困境 [9] 公司整体情况 - Lucid的亏损、资产负债表和竞争环境使其处境艰难没有更多资本无法生存且难以达到可持续发展状态股票不值得购买且看不到复苏前景 [10]

A financial researcher and avid investor with a keen eye for innovation and disruption, as well as growth buy-outs and value stocks. Keeping an eye on the pace of high tech and early growth companies, I write about current events and the biggest news surrounding the industry, and strive to provide readers with ample research and investment opportunities.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positio ...

NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Lucid Group (NASDAQ: LCID) on behalf of long-term stockholders following a class action complaint that was filed against Lucid on April 1, 2022 with a Class Period from November 15, 2021 to August 3, 2022. Our investigation concerns whether the board of directors of Lucid have breached their fiduciary duties to the company. The Lucid class-ac ...

NEW YORK, Nov. 20, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has submitted its complete clinical evidence package for its EsoGuard® Esophageal DNA Test in support of a Request for Reconsideration of Local Coverage Determination (LCD) L39256 "MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, an ...

After weeks of extended losses, electric vehicle manufacturer Lucid Motors (NASDAQ: LCID) is striving to stabilize its valuation above $2.The equity, currently valued at $2.14, ended the last trading session up 6.47%. However, on the weekly chart, LCID is down almost 8%.Ahead of trading on November 19, the stock is signaling an inability to sustain the previous session’s momentum, down 0.47% in the pre-market. LCID one-week stock price chart. Source: FinboldLCID share price needs to target the $3 resistance ...

文章核心观点 - 尽管Lucid Motors公司股票在近一个月和近七日处于下跌状态，但11月18日周一突然大幅上涨，上涨原因不明确，可能是向上修正，也可能与CEO言论有关，但不能确定投资者信心完全来自CEO言论，且若此次上涨短暂也不足为奇[1][2][4][8][9] 根据相关目录分别进行总结 股票价格走势 - Lucid Motors公司股票在过去30天大幅下跌，一个月内下跌16.08%，七日下跌7.75%，但在11月18日的最后一个交易日上涨6.47%，收盘价为2.14美元，周二盘前上涨0.47%，上涨趋势可能会持续但不明确[1][2][3] 股票上涨驱动因素 - 股票上涨没有明显驱动因素，贝莱德显著减持公司股票，可能只是一种向上修正，也许是投资者对公司新车型计划的失望情绪耗尽了下跌动力，Lucid公司CEO的一些言论可能给交易者带来了一些信心，但不能确定投资者信心完全来自CEO言论[4][5][8] CEO言论内容 - Lucid公司CEO表示不会有低成本车型，公司技术成就有助于推动20000美元电动汽车发展，将公司与保时捷类比，称公司是行业内最不受不利政策变化影响的公司，还认为公司从特斯拉手中夺走了技术领先地位，且表示特斯拉股票上涨更多是特朗普 - 马斯克政治联盟的结果而非特斯拉自身优势[5][6][7] 股票未来走势 - 如果Lucid公司股票此次上涨是短暂的也不足为奇，因为公司之前有过多次短暂剧烈上涨后迅速失去动力的情况，目前公司股价较首次公开发行价下跌78.36%[9]

The world’s largest asset manager, BlackRock (NYSE: BLK) holds stock in more than 5,000 businesses. The sheer scale of the investment giant’s dealings is tough to comprehend — but honing in on how the company treats specific businesses can serve as a worthwhile barometer.As one of the players at the forefront of ESG (environmental, social, and governance) investing, Blackrock’s focus on renewables has led it to invest in numerous ventures that are tackling the issue of climate change. One such company is Lu ...

NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, November 21, 2024 at 1:30 p.m. ET.Live and replay webcasts may be accessed on the investor relations section of the Company's website ...

文章核心观点 - Lucid公司股票在2024年及之后持续下跌且技术分析显示有更大的下跌趋势其11月14日晚形成死亡交叉模式之前已下跌49.52%到2.10美元可能重复之前死亡交叉后的下跌趋势从而失去投资价值和行业竞争力 [1][2][3] Lucid公司情况 - 股票表现：11月14日在纳斯达克收盘价为2.08美元较前一交易日下跌0.10美元跌幅4.59%盘后价为2.10美元上涨0.02美元涨幅1.20% [2] - 业绩表现：年初至今股价已下跌49.52% [3][10] - 未达目标：原本被视为特斯拉杀手但未达到投资者期望和自身承诺如2024年上半年交付目标差约90% [12] - 产品定价：即将推出的新款SUV定价高于94000美元且2025年之前无更低价产品令投资者失望 [12] - 未来挑战：美国政策变化可能使公司高端产品销售问题恶化如特朗普政府准备削减7500美元电动汽车税收抵免政策可能使公司市场份额进一步下降导致更多交付目标无法达成 [13][14][15]

Lucid is stuck in first gear and struggling to get going.Like many other electric vehicle start-ups right now, Lucid Group (LCID 1.87%) is trying to find its footing in an increasingly competitive market. The company's impressive Air sedan has caught the automotive world's attention, but its stock has failed to impress investors.So, where is Lucid headed over the next year? I think the company is in for a bumpy ride and could face some of the same production and funding issues it's currently dealing with. H ...